BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 28465324)

  • 1. Potentiation of receptor responses induced by prolonged binding of Gα
    Bodmann EL; Krett AL; Bünemann M
    FASEB J; 2017 Aug; 31(8):3663-3676. PubMed ID: 28465324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulated localization is sufficient for hormonal control of regulator of G protein signaling homology Rho guanine nucleotide exchange factors (RH-RhoGEFs).
    Carter AM; Gutowski S; Sternweis PC
    J Biol Chem; 2014 Jul; 289(28):19737-46. PubMed ID: 24855647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galpha 12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF.
    Suzuki N; Nakamura S; Mano H; Kozasa T
    Proc Natl Acad Sci U S A; 2003 Jan; 100(2):733-8. PubMed ID: 12515866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct regions of Galpha13 participate in its regulatory interactions with RGS homology domain-containing RhoGEFs.
    Kreutz B; Hajicek N; Yau DM; Nakamura S; Kozasa T
    Cell Signal; 2007 Aug; 19(8):1681-9. PubMed ID: 17449226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Critical role of lysine 204 in switch I region of Galpha13 for regulation of p115RhoGEF and leukemia-associated RhoGEF.
    Nakamura S; Kreutz B; Tanabe S; Suzuki N; Kozasa T
    Mol Pharmacol; 2004 Oct; 66(4):1029-34. PubMed ID: 15258251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modification of p115RhoGEF Ser(330) regulates its RhoGEF activity.
    Chow CR; Suzuki N; Kawamura T; Hamakubo T; Kozasa T
    Cell Signal; 2013 Nov; 25(11):2085-92. PubMed ID: 23816534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gα
    Castillo-Kauil A; García-Jiménez I; Cervantes-Villagrana RD; Adame-García SR; Beltrán-Navarro YM; Gutkind JS; Reyes-Cruz G; Vázquez-Prado J
    J Biol Chem; 2020 Dec; 295(50):16920-16928. PubMed ID: 33023908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation.
    Mikelis CM; Palmby TR; Simaan M; Li W; Szabo R; Lyons R; Martin D; Yagi H; Fukuhara S; Chikumi H; Galisteo R; Mukouyama YS; Bugge TH; Gutkind JS
    J Biol Chem; 2013 Apr; 288(17):12232-43. PubMed ID: 23467409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of leukemia-associated RhoGEF by Galpha13 with significant conformational rearrangements in the interface.
    Suzuki N; Tsumoto K; Hajicek N; Daigo K; Tokita R; Minami S; Kodama T; Hamakubo T; Kozasa T
    J Biol Chem; 2009 Feb; 284(8):5000-9. PubMed ID: 19074425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction kinetics between p115-RhoGEF and Gα
    Redlin F; Krett AL; Bünemann M
    Commun Biol; 2022 Nov; 5(1):1287. PubMed ID: 36434027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the expression of PDZ-RhoGEF, LARG and G(alpha)12/G(alpha)13 proteins in the murine nervous system.
    Kuner R; Swiercz JM; Zywietz A; Tappe A; Offermanns S
    Eur J Neurosci; 2002 Dec; 16(12):2333-41. PubMed ID: 12492428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of RGS-RhoGEFs by Galpha12 and Galpha13 proteins.
    Tanabe S; Kreutz B; Suzuki N; Kozasa T
    Methods Enzymol; 2004; 390():285-94. PubMed ID: 15488184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leukemia-associated Rho guanine nucleotide exchange factor promotes G alpha q-coupled activation of RhoA.
    Booden MA; Siderovski DP; Der CJ
    Mol Cell Biol; 2002 Jun; 22(12):4053-61. PubMed ID: 12024019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of neurite morphogenesis by interaction between R7 regulator of G protein signaling complexes and G protein subunit Gα
    Scherer SL; Cain MD; Kanai SM; Kaltenbronn KM; Blumer KJ
    J Biol Chem; 2017 Jun; 292(24):9906-9918. PubMed ID: 28432124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sphingosine 1-phosphate receptor 2 signals through leukemia-associated RhoGEF (LARG), to promote smooth muscle cell differentiation.
    Medlin MD; Staus DP; Dubash AD; Taylor JM; Mack CP
    Arterioscler Thromb Vasc Biol; 2010 Sep; 30(9):1779-86. PubMed ID: 20702813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detrimental Role of PDZ-RhoGEF in Pathological Cardiac Hypertrophy.
    Huang J; Qu Q; Dai Y; Ren D; Qian J; Ge J
    Hypertension; 2023 Feb; 80(2):403-415. PubMed ID: 36448462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring hotspot cancer mutations in Gα
    Maziarz M; Federico A; Zhao J; Dujmusic L; Zhao Z; Monti S; Varelas X; Garcia-Marcos M
    J Biol Chem; 2020 Dec; 295(49):16897-16904. PubMed ID: 33109615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent C-terminal motifs in Gα12 and Gα13 provide distinct mechanisms of effector binding and SRF activation.
    Stecky RC; Quick CR; Fleming TL; Mull ML; Vinson VK; Whitley MS; Dover EN; Meigs TE
    Cell Signal; 2020 Aug; 72():109653. PubMed ID: 32330601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic-dependent phosphorylation of leukemia-associated RhoGEF (LARG) by Cdk1.
    Helms MC; Grabocka E; Martz MK; Fischer CC; Suzuki N; Wedegaertner PB
    Cell Signal; 2016 Jan; 28(1):43-52. PubMed ID: 26483157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of Leukaemia Associated Rho GEF (LARG/ARHGEF12).
    Ghanem NZ; Matter ML; Ramos JW
    Small GTPases; 2022 Jan; 13(1):196-204. PubMed ID: 34304710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.